New gene panel enhances brain tumor profiles: Cristiane (Cris) Ida, M.D.
Cristiane (Cris) Ida, M.D., explains how Mayo Clinic Laboratories' updated neuro-oncology gene panel provides more clinically relevant information for managing adult and pediatric brain tumors.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:31)
Could you provide our listeners with a little bit about yourself and your background?
(01:48)
Could you give an overview of the new neuro-oncology expanded gene panel by next generation sequencing?
(03:43)
Can you describe a little bit more about some examples of genes that were in the 2021 WHO classification that are now included in the NONCP panel?
(06:50)
Does this panel have high clinical utility in both in adult and pediatric cases?
(08:05)
Is picking up on copy numbers useful in both adult and pediatric cases?
(09:12)
Could you discuss a little bit more about how these results would be used in patient care?
(10:27)
Do you have anything else you would like to add about the enhanced neuro-oncology NGS panel?